secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0000064803-24-000015
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q1 GAAP EPS $0.88 vs $1.65; FY2024 guidance slashed on Medicare pressure
--------------------------------------------------------------------------------

- Q1 revenues rose 3.7% to $88.4B; GAAP diluted EPS $0.88 vs $1.65; adjusted EPS $1.31 vs $2.20.
- Operating income fell to $2.3B from $3.4B; Health Care Benefits segment pressured by Medicare utilization.
- FY2024 guidance cut: GAAP EPS at least $5.64 (from $7.06); Adj EPS at least $7.00 (from $8.30).
- Q1 cash flow from operations $4.9B; FY guidance reduced to at least $10.5B from $12.0B.
- CEO cites Medicare Advantage challenges; expects elevated cost trends to persist through 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000015/0000064803-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000015/cvs-20240501.htm
  HTML page:      https://secwatch.observer/filing/0000064803-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer